Sept 12 (Reuters) - Eiger BioPharmaceuticals Inc said on Tuesday it would discontinue a late-stage study testing its experimental drug to treat the most severe form of viral hepatitis. (Reporting by Mariam Sunny in Bengaluru)
Eiger to discontinue hepatitis drug study
![Reuters logo](/images/reuters.jpg)